一个患者报告规模研究,以获取IgA脏病患者的症状负担
Nan Yang1,2, Jiyu Tang2, Xiaodi Li3
1Graduate School of Clinical Medicine, Jinzhou Medical University, Jinzhou, Liaoning, China.
Scientific reports
|September 27, 2024
概括
IgA脏病 (IgAN) 患者面临着严重的症状负担,影响日常生活. 这项研究开发了一种新的Igan症状评估工具,以有效地评估这些身体和心理挑战.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床研究 临床研究
- 患者报告的结果
背景情况:
- IgA 病 (IgAN) 患者经历了相当大的身体和心理症状负担.
- 缺乏标准化工具来评估Igan中的症状负担.
- 有效的症状评估对于改善患者的生活质量至关重要.
研究的目的:
- 开发和验证一个Igan症状评估工具.
- 为了全面评估IGAN患者的症状负担和自我认知的严重程度.
- 为临床使用和研究提供标准化的仪器.
主要方法:
- 预期的观察性研究设计.
- 开发Igan症状负担评估尺度的发展.
- 在中国,对200名Igan患者进行了14项问卷调查.
- 症状严重程度使用5分利克尔特等级来评估.
主要成果:
- 开发的尺度有效地捕捉了IGAN患者的症状负担.
- 几乎所有接受调查的患者都报告了普遍和具有影响力的症状.
- 常见的症状包括轻度寡尿症,中度鼻塞,苦味,喉不适,肌肉虚弱,疲劳和发泡的尿液.
- 在研究的Igan群体中证实了显著的症状负担.
结论:
- 显著的症状负担显著影响Igan患者的日常生活.
- 新开发的Igan症状评估工具是评估患者症状负担的宝贵工具.
- 优先考虑症状管理和使用验证的评估工具对于最佳的Igan患者护理至关重要.
相关概念视频
01:17Assessment of the Gastrointestinal System I: Subjective Data
152
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
152
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
81
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
81
01:26Nephrotic Syndrome II : Assessment and Medical Management
2
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
2
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
146
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
146
01:24Nephrotic Syndrome III : Nursing Management
2
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
2
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
174
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
174